The Community Focus Channel on VJHemOnc is an independent medical education platform, supported with funding from Johnson & Johnson (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Non-Malignant Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Sickle Cell Disease Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ASCAT 2023 | The importance of RBC exchange transfusions for managing fat embolism syndrome in SCD
Perla Eleftheriou, MD, MRCP, FRCPath, University College London Hospitals NHS Foundation Trust, London, UK, speaks on fat embolism syndrome (FES) in sickle cell disease (SCD), highlighting the unique nature of each case and elaborating on the high-risk patient groups often exhibiting this complication. Despite no guidelines existing for its treatment, Dr Eleftheriou emphasizes the need for red blood cell (RBC) exchange transfusions early on in FES treatment regimens to improve outcomes of patients. This interview took place at the 18th Annual Scientific Conference on Sickle Cell and Thalassemia (ASCAT) 2023, held in London, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
